Skip to content

A multicenter randomized controlled study of hot steam ablation in treatment of type III prostatitis

A multicenter randomized controlled study of hot steam ablation in treatment of type III prostatitis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500098306
Enrollment
Unknown
Registered
2025-03-05
Start date
2025-06-01
Completion date
Unknown
Last updated
2025-03-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type III prostatitis

Interventions

Intervention group :Thermal steam ablation surgery combined with Tamsulosin
Control group :Intervention with Tamsulosin

Sponsors

Shanghai Tongji Hospital
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
20 Years to 80 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: According to the diagnostic criteria of the Chinese Guidelines for the Diagnosis and Treatment of Urology Diseases (2024 edition), patients aged between 20 and 80 years old were selected to be diagnosed with type III prostatitis, pelvic pain, urination discomfort and NIH-CPSI score >=15, and prostatic hyperplasia (volume >30ml) with symptoms of urination dysfunction. Routine prostatic fluid examination: White blood cells >10 /HP, the number of lecithin bodies decreased, urine routine examination was normal, the bacterial culture result of prostate massage fluid (EPS) was negative. Persons who have used Nonsteroidal Antiinflammatory Drugs (NSAIDs), alpha-blockers, and antimicrobials in the recent period are ineffective in treatment.

Exclusion criteria

Exclusion criteria: Exclusion criteria: Patients with gonococcal urethritis and non-gonococcal urethritis were excluded. Exclude patients with urinary calculi and other urinary tract diseases caused by abnormal urination function or accompanied by urinary tract irritation symptoms; Exclude patients with spermatic cord, testis, epididymis and other diseases that can cause abnormal urination and dull pain and discomfort of pelvic floor; Exclude patients with severe medical system disease that can affect the function of the lower urinary tract; Exclude patients who terminate themselves midway or fail to take regular drugs as required.

Design outcomes

Primary

MeasureTime frame
maximum urine flow rate;Prostatic thermal steam ablation operation time;NIH-CPSI ;HAMA;HAMD;residual urine;

Secondary

MeasureTime frame
Prostatic fluid secretes white blood cells;

Countries

China

Contacts

Public ContactDenglong Wu

Shanghai Tongji Hospital

wudenglong@163.com+86 136 2163 4001

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026